Latest Multi-drug-resistant tuberculosis Stories
The European Respiratory Journal is today (04 August 2011) publishing the updated guidelines of the World Health Organization (WHO) that aim to help manage drug-resistant tuberculosis (TB).
Two research studies suggest that a new automated DNA test for tuberculosis (Xpert MTB/RIF), which can detect TB within 2 hours and has been endorsed by the World Health Organization, can significantly increase TB detection rate compared to other tests, particularly in HIV positive patients who have a high risk of being infected with TB, including multidrug resistant TB.
Patients with tuberculosis (TB) who wear a simple facemask may be able to greatly cut transmission rates to non-infected patients, according to a study conducted on guinea pigs.
Tuberculosis (TB) is widely considered a public health concern and its treatment a public sector responsibility.
MSF report says fixing drug supply and price problems is urgent Geneva / Johannesburg (Vocus/PRWEB) March 24, 2011 A promising new diagnostic test will finally help detect more people with drug-resistant tuberculosis (DR-TB), a development that lends greater urgency to solve major problems surrounding the pricing and supply of DR-TB medicines, according to a report released today by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières...
The standard approach to re-treating tuberculosis (TB) in low and middle income settings is failing.
The standard retreatment regimen for tuberculosis has low treatment response rates and is associated with poor long term outcomes in certain subgroups of patients, particularly those infected with both HIV and multi-drug resistant TB.
INDIANAPOLIS, Dec. 23, 2010 /PRNewswire/ -- BioCrossroads' Indiana Seed Fund has announced its eleventh investment, committing $250,000 to biotech start-up Aarden Pharmaceuticals.
WASHINGTON, Dec. 8, 2010 /PRNewswire-USNewswire/ -- Following is the text of a joint statement by the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), U.S. Agency for International Development and U.S.
China had an estimated 1.3 million new cases of tuberculosis (TB) in 2008, of which 112,000 were multi-drug resistant (MDR-TB).